Key Documents
Christopher Ta, MD
Academic Appointments
- Associate Professor - Med Center Line, Ophthalmology
- Member, Bio-X
Contact Information
-
Clinical Offices
Ophthalmology Clinic 900 Blake Wilbur Dr W3002 MC 5353 Palo Alto, CA 94304 Tel Work (650) 723-6995 Fax (650) 725-6619Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Administrative Contact Theresa Menzies Administrative Assistant Tel Work 650-725-5743Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Ophthalmology
Administrative Appointments
- Residency Program Director, Ophthalmology (2003 - present)
Professional Education
| Board Certification: | Ophthalmology, American Board of Ophthalmology (2000) |
| Fellowship: | Univ Of Texas Southwestern, TX (1999) |
| Residency: | SUMC - Graduate Medical Education, CA (1998) |
| Internship: | Kaiser Foundation Hospital-Oakland, CA (1995) |
| Medical Education: | University of Minnesota, MN (1994) |
Graduate & Fellowship Program Affiliations
Web Site Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Lux , Vistakon |
Scientific Focus
Current Research Interests
Dr. Ta is the PI for two major research projects:
(1) Development of an artificial cornea
(2) Ocular microbiology - prevention and treatment of ocular infectious diseases.
Clinical Trials
Publications
- Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery. Eur J Ophthalmol. 2009 Sep-Oct; (5): 717-22
- Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria. J Ocul Pharmacol Ther. 2009; (4): 373-8
- One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus. J Cataract Refract Surg. 2009; (10): 1715-8
- In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria. Eye (Lond). 2009; (3): 559-60
- Bioactive interpenetrating polymer network hydrogels that support corneal epithelial wound healing. J Biomed Mater Res A. 2009; (1): 70-81
Help